We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Our shares are listed on the SIX Swiss Exchange (NWRN).
April 7-9, 2019 - Grosvenor House, London, UK
February 27 - March 1, 2019 - Lotte New York Palace Hotel, New York, USA
February 11-12, 2019 - Marriott Marquis, New York, NY, USA